Hermes J Florez

Professor

  • 8467 Citations
19952020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Hermes J Florez is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 18 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

GENERAL CLINICAL RESEARCH CENTER

Alejandro, R., Saab, P., Weiss, S. M., Antoni, M. H., Feaster, D. J., Florez, H. J., Schneiderman, N., Hurwitz, B., Clarkson, J., Goldberg, R., Penedo, F., Elsas, L., Goldschmidt-Clermont, P., Ramsey, R. E., Scott, G. B., Levis, S., Berkovitz, G. D., Miguez, M., Haslett, P. A. J., Sipski, M., Marks, J., Goodkin, K., Ramsay, E., Jayaraman, S., Hoffman, R. W., Duara, S., Bandstra, E. S., Nash, M. S. & Scott, G. B.

National Institutes of Health

8/15/029/30/07

Project: Research project

Research Output

Open Access
  • The Association of Frailty with Hospitalizations and Mortality among Community Dwelling Older Adults with Diabetes

    Ferri-Guerra, J., Aparicio-Ugarriza, R., Salguero, D., Baskaran, D., Mohammed, Y. N., Florez, H. & Ruiz, J. G., 2020, In : The Journal of frailty & aging. 9, 2, p. 94-100 7 p.

    Research output: Contribution to journalArticle

  • Baseline characteristics of randomized participants in the glycemia reduction approaches in diabetes: A comparative effectiveness study (GRADE)

    Wexler, D. J., Krause-Steinrauf, H., Crandall, J. P., Florez, H. J., Hox, S. H., Kuhn, A., Sood, A., Underkofler, C. & Aroda, V. R., Nov 1 2019, In : Diabetes care. 42, 11, p. 2098-2107 10 p.

    Research output: Contribution to journalArticle

    Open Access
  • 4 Scopus citations

    Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

    REWIND Investigators, Jul 13 2019, In : The Lancet. 394, 10193, p. 121-130 10 p.

    Research output: Contribution to journalArticle

  • 360 Scopus citations

    Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

    REWIND Investigators, Jul 13 2019, In : The Lancet. 394, 10193, p. 131-138 8 p.

    Research output: Contribution to journalArticle

  • 99 Scopus citations